Navigation Links
Brazil's Rheumatoid Arthritis Drug Market Will Grow $115 Million by 2013
Date:7/20/2009

WALTHAM, Mass., July 20 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in Brazil will grow from $200 million in 2008 to more than $315 million in 2013. The 2008 market leaders were the tumor necrosis factor-alpha (TNF-alpha) inhibitors Abbott's Humira and Schering-Plough's Remicade which recorded sales of $50 million and $43 million, respectively, despite a combined patient share of two percent. Wyeth's Enbrel, the third marketed agent from this class, recorded fewer sales because of its inconvenient dosing frequency and its availability only in a lyophilized form.

The new Emerging Markets report entitled Rheumatoid Arthritis in Brazil also finds that survey results of Brazilian rheumatologists show regional differences in their preferences for agents within key drug classes for rheumatoid arthritis. While Enbrel emerges as the patient share leader among biologics in Rio de Janeiro, rheumatologists from Sao Paulo and Belo Horizonte prefer Humira and Remicade, respectively.

"Competition among TNF-alpha inhibitors is influenced by a drug's clinical profile, order of market entry, ease of access in the public sector, patients' socioeconomic status, ease of administration and marketing campaigns," stated Irene Koulinska, Sc.D., M.D.

The new report is part of an expansion of the Emerging Markets report series to cover Brazil. The series contains primary research of physicians and epidemiology study in key pharmaceutical markets of Brazil--Rio de Janeiro, Sao Paulo and Belo Horizonte.

About Emerging Markets Reports

Decision Resources is the FIRST and ONLY company to offer a syndicated re
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Chinas Rheumatoid Arthritis Drug Market Will More than Double by 2013
2. New Drug Promising Against Rheumatoid Arthritis
3. Over half of people with rheumatoid arthritis have periodontitis
4. Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis
5. Rheumatoid arthritis is associated with poor sleep in women
6. Rheumatoid Arthritis Drug Might Fight Swine Flu
7. Treating gum disease helps rheumatoid arthritis sufferers
8. For the Treatment of Rheumatoid Arthritis, Market Share for TNF-alpha Inhibitors Will Decrease Through 2018
9. Nektar Announces UCBs Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
10. UCBs CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
11. SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...1 With employee benefit ... employers are providing self-service decision-mak..., according to a new survey by Watson Wyatt, a lea...rs who offer these tools believe they lead employe...According to the survey, 45 percent of companies o...
(Date:12/1/2009)..., Dec 1 Edifecs, Inc., the proven ...ization solutions announced an enhanced release of... 4010A1 to HIPAA 5010 migrations. XEngine Translat...maps, allows generation of test data and permits t...uction, thus addressing most requirements for orga...
(Date:12/1/2009)...rming, isolating behaviors jump from friend to fr...) -- A new study suggests that lonely people attra...lonely, too. , "Loneliness can spread from pers...eparation," said James H. Fowler, co-author of the...rnal of Personality and Social Psychology , and pr...
(Date:12/1/2009)... thought you could quit smoking while you,re still...breaking new system for quitting is easy, painless...eight days your cravings and desire to smoke will ...PRWEB) December 1, 2009 -- Izabella had tried to q...n to nicotine, smoking at least a pack a day. , ,...
(Date:12/1/2009)...1 Individuals in consum...n those with traditional coverage to exhibit a num...d in wellness programs, and to be more inclined to... down costs, according to survey results released ... Institute (EBRI). ,, At the same time, the fi...
Breaking Medicine News(10 mins):Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4
...ctal cancer causes about 10 percent of cancer deat... have one more option // for patients who have col...treatment. New research shows the drug cetuximab, ...t can be given alone or with fluorouracil (Adrucil...
...search shows while obesity may increase a person’s...thy diet may have the opposite effect.// In a r... 1,500 participants for more than 20 years. They f... pressure in middle age were six-times more likely...
...ary fibrosis is a progressive lung disease that, a...ims the lives of 40,000 people every year. There's...me occupations are risk factors. Now, a new treatm...ar, his doctor told him he had a lung disease call...
...safe for people with heart disease to travel by ai...t medical evidence on // issues involving air trav...r travel and security devices on implantable autom...t can arise in the leg when air travelers sit for ...
...te cancer is the most common cancer diagnosed amon...,000 men every year. There are several // treatmen...ay to prevent the disease altogether. Doctors ...ness. It works by stopping testosterone’s conversi...
...ts with rheumatoid arthritis who receive a more in...nce a remission of their disease, finds a new stud...ned 111 patients with similar levels of disease to... received standard care, which consisted of treatm...
Other Medicine News:Health News:Gleevec for Lung Disease 2
(Date:12/1/2009)...wswire-FirstCall/ -- An expert from PAREXEL Intern...obal biopharmaceutical services provider, will lea...rug development in Asia at the Partnerships in Cli...ecember 1-3, 2009 at the Intercontinental Hotel in..., which is focused on maximizing efficiency and ma...
(Date:11/30/2009)...ewswire/ -- Nonin Medical, Inc., a leading innovat...nventor of fingertip pulse oximetry, was awarded F...ne Strategy Award in Remote Patient Monitoring. Re...siological monitoring, Nonin Medical was acknowled...lemedicine monitoring equipment. ,, The Product...
(Date:11/30/2009)...re-FirstCall/ -- DATATRAK International, Inc. (OTC...ed on global eClinical solutions for the clinical ...ocus AG (PFC) has joined its CRO Connect Program. ...TRAK,s CRO partner training and offer its clients ...tion, PFC will also have access to Partner preferr...
Breaking Medicine Technology:PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 3PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4VBI researchers develop new method for breast cancer biomarker discovery 48362 1VBI researchers develop new method for breast cancer biomarker discovery 48362 2Clock Ticking In Boston Archdiocese Abortion Scandal 48361 1Clock Ticking In Boston Archdiocese Abortion Scandal 48361 2Courage Center Is First in Midwest to Offer Innovative Treatment for Movement Disorders 48358 1Courage Center Is First in Midwest to Offer Innovative Treatment for Movement Disorders 48358 2
...enol(R) boosts healthy NO production, increasing b...ply, HOBOKEN, N.J., Oct. 17 A study to be publis...h reveals Pycnogenol(R),(pic-noj-en-all), an antio...aritime pine tree, helps individuals by enhancing ...o an increase in blood flow and oxygen supply,to m...
...er Trial to Compare Genous vs. Drug-Eluting and Ba...TERDAM, Netherlands, Oct. 17 Enrollment in the,ra...l of OrbusNeich,s,Genous Bio-engineered R stent ha... trial in April, according to Robbert de Winter, M...the catheterization laboratory at,the Academic Med...
Other Medicine Technology:New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 2New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 3Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2
STA STACLOT PROTEIN C
ASSERACHROM PROTEIN C
STA DEFICIENT II
STA DEFICIENT IX
Medicine Products: